HPIC Stock Overview
Engages in the manufacture and marketing of generic pharmaceutical products in Jordan. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Hayat Pharmaceutical Industries Co. PLC Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | د.أ2.97 |
| 52 Week High | د.أ2.99 |
| 52 Week Low | د.أ2.41 |
| Beta | 0.18 |
| 1 Month Change | 9.59% |
| 3 Month Change | 18.33% |
| 1 Year Change | 18.33% |
| 3 Year Change | -22.45% |
| 5 Year Change | 57.14% |
| Change since IPO | 58.82% |
Recent News & Updates
Recent updates
Shareholder Returns
| HPIC | JO Pharmaceuticals | JO Market | |
|---|---|---|---|
| 7D | 2.4% | 1.9% | 0.7% |
| 1Y | 18.3% | 2.3% | 10.2% |
Return vs Industry: HPIC exceeded the JO Pharmaceuticals industry which returned 2.3% over the past year.
Return vs Market: HPIC exceeded the JO Market which returned 10.2% over the past year.
Price Volatility
| HPIC volatility | |
|---|---|
| HPIC Average Weekly Movement | 5.0% |
| Pharmaceuticals Industry Average Movement | 5.0% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in JO Market | 5.6% |
| 10% least volatile stocks in JO Market | 1.8% |
Stable Share Price: HPIC's share price has been volatile over the past 3 months compared to the JO market.
Volatility Over Time: HPIC's weekly volatility (5%) has been stable over the past year, but is still higher than 75% of JO stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 234 | Maher Mohammed Al Kurdi | www.hayatpharma.com |
Hayat Pharmaceutical Industries Co. PLC engages in the manufacture and marketing of generic pharmaceutical products in Jordan. It offers products in various therapeutic areas, such as allergies; cardiovascular system; dermatology; gastrointestinal system; infectious disease; inner ear and balance; neurology; pain and inflammation; respiratory system; and vitamins and supplements, as well as men’s and women’s health products. The company was founded in 1994 and is based in Amman, Jordan.
Hayat Pharmaceutical Industries Co. PLC Fundamentals Summary
| HPIC fundamental statistics | |
|---|---|
| Market cap | د.أ28.22m |
| Earnings (TTM) | د.أ3.09m |
| Revenue (TTM) | د.أ16.71m |
9.1x
P/E Ratio1.7x
P/S RatioIs HPIC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HPIC income statement (TTM) | |
|---|---|
| Revenue | د.أ16.71m |
| Cost of Revenue | د.أ7.45m |
| Gross Profit | د.أ9.26m |
| Other Expenses | د.أ6.17m |
| Earnings | د.أ3.09m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.33 |
| Gross Margin | 55.40% |
| Net Profit Margin | 18.49% |
| Debt/Equity Ratio | 12.4% |
How did HPIC perform over the long term?
See historical performance and comparisonDividends
7.4%
Current Dividend Yield68%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/23 01:51 |
| End of Day Share Price | 2025/03/23 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Hayat Pharmaceutical Industries Co. PLC is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.